Covance, Pathoquest Collaborate on NGS Safety Platform
November 7, 2013 | Covance and Pathoquest have signed an agreement to build an NGS-based biosafety assessment platform. The platform would detect contaminants within monoclonal antibodies or vaccines. Outsourcing Pharma
Click here to log in.
Text Only 2000 character limit
Page 1 of 1